Bringing together over 14,000 delegates ECCMID 2022 is an important congress in the field of infection control. Explore this rapidmicrobiology special focus and find out What's on Show in the exhibition halls.
Puritan® specimen collection and transport devices, designed for convenience and accuracy.
Our line of swabs and transport devices are available in several different configurations of handles and tip styles as well as various tip materials, including cotton, rayon, polyester, calcium alginate, and foam. Plus, our patented PurFlock Ultra® and
Sino Biological has now launched recombinant HA, NA, and NP proteins for 2022-2023 influenza vaccine strains, adding to its comprehensive collection of influenza antigens from all WHO-recommended vaccine strains in recent years. These antigens can be used to analyze vaccine-induced antibody response.
Omicron BA.2 sub-lineage has been increasing in many countries in recent months. It’s urgent to investigate immune escape properties and virulence of BA.2. Sino Biological has developed a panel of recombinant RBD/Spike and nucleocapsid protein variants which can be used to evaluate the efficacy of the antibodies and vaccination.
For the collection and preservation of viruses, chlamydia, mycoplasma and ureaplasma, Puritan® UniTranz-RT®, with our patented PurFlock Ultra® flocked swabs, available in various tip shapes and sizes appropriate for various collection sites.
And, for aerobic, anaerobic, and fastidious bacteria sampling, our Puritan® Opti-Swab® featuring our patented
INTEGRA Biosciences has created the D-ONE single channel pipetting module for hands-free transfers from individual tubes or wells using the ASSIST PLUS pipetting robot. This system effectively automates tedious tasks such as serial dilutions, sample normalization, hit picking or pipetting of complex plate layouts, increasing productivity and reproducibility in the lab while
Sino Biological has developed recombinant Omicron Spike (RBD, S1, S2, S-ECD, S-NTD, S Trimer) and Nucleocapsid proteins and evaluated antibodies reacting with Omicron to support the study of Omicron variant.